Capstone Investment Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Capstone Investment Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,421	Closed	-$353K	–	2566
2024 Q1	$353K	Buy	+22,421	New	+$345K	﹤0.01%	1742

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Capstone Investment Advisors's DCPH Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 22,421 shares — an estimated $353K sold.

Capstone Investment Advisors first reported a position in DCPH in Q1 2024 and held it in 1 quarter. The position peaked at $353K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Capstone Investment Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Capstone Investment Advisors sold 22,421 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $353K.
Capstone Investment Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Capstone Investment Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $353K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.